Archive:: International Journal of Clinical Oncology and Cancer Research:: Science Publishing Group

Volume 10, Issue 2, June 2025

Research Article
Comparative Prospective Study Assessing Early Clinical Outcomes with or Without Use of Contrast Enhancement in CT Based Image Guided HDR Brachytherapy

Shreya Dwivedi^*, Aswin Chandran Veluthattil, Madhulika Vijayakumar, Nithiyaanandan Natarajan, Anjali Thiruthiyil, Dinesh Babu, Shankar Sekar

Issue: Volume 10, Issue 2, June 2025

Pages: 36-50

Received: 3 March 2025

Accepted: 12 March 2025

Published: 26 March 2025

DOI: 10.11648/j.ijcocr.20251002.11

Downloads:

Views:

Abstract: Background: Brachytherapy has been part of the standard of care in the treatment of cervical cancer. Brachytherapy has evolved from two to three-dimensional treatment for better volume delineation for target and OAR thus leading to better LC and reduced toxicities. Presently, MR Brachytherapy is the gold standard. However, its use is limited by its... Show More

Download PDF

View Online
Research Article
Evaluation of Response and Toxicity of Pemetrexed-Carboplatin Versus Paclitaxel-Carboplatin as First-Line Treatment in Metastatic NSCLC

Uday Kumar Sarkar^*, Sarwar Alam, Syed Md Asadul Hoque, Newton Kumar Sarker, Tasnim Mahmud, Safayet Hossain

Issue: Volume 10, Issue 2, June 2025

Pages: 51-58

Received: 2 March 2025

Accepted: 12 March 2025

Published: 28 March 2025

DOI: 10.11648/j.ijcocr.20251002.12

Downloads:

Views:

Abstract: Non-small cell lung cancer (NSCLC) accounts for 80-85% of all lung cancer approximately. The paclitaxel-carboplatin combination is the established standard regimen of choice in metastatic NSCLC. Pemetrexed, a folate antimetabolite is also effective against non-small cell lung cancer. To compare the response and toxicity of the Pemetrexed-Carboplati... Show More

Download PDF

View Online